🔴 چراغ سبز چین به استفاده از داروی Actemra (tocilizumab) در بیماران covid19 .
کلینیکال ترایالی با پیش‌بینی آزمایش میان ۱۸۸ بیمار Covid-19 در چین برای بررسی اثر Actemra در حال جریان است. این کلینیکال تریال ده می به پایان میرسد.
نتایج اولیه روی ۱۴ بیمار اولیه با درگیری شدید ریه نشان داده که این دارو میتواند به روند درمان این بیماران کمک کند.
#کرونا #COVID19
The drug is capable of inhibiting high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.
It was first cleared by the US Food and Drug Administration (FDA) as a treatment for rheumatoid arthritis and subsequently picked up additional approvals in juvenile idiopathic arthritis, giant cell arteritis and CRS associated with CAR-T cell therapies for cancer.
There is no efficacy or safety data yet to support the use of Actemra in COVID-19 infections, but Chinese researchers are carrying out an 188-patient clinical trial in patients infected with the virus. Preliminary results in 14 patients have suggested however it may be able to help in subjects who have progressed to severe lung disease.
https://www.pmlive.com/pharma_news/china_backs_use_of_roches_actemra_for_coronavirus_1328014?SQ_DESIGN_NAME=2&
کلینیکال ترایالی با پیش‌بینی آزمایش میان ۱۸۸ بیمار Covid-19 در چین برای بررسی اثر Actemra در حال جریان است. این کلینیکال تریال ده می به پایان میرسد.
نتایج اولیه روی ۱۴ بیمار اولیه با درگیری شدید ریه نشان داده که این دارو میتواند به روند درمان این بیماران کمک کند.
#کرونا #COVID19
The drug is capable of inhibiting high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.
It was first cleared by the US Food and Drug Administration (FDA) as a treatment for rheumatoid arthritis and subsequently picked up additional approvals in juvenile idiopathic arthritis, giant cell arteritis and CRS associated with CAR-T cell therapies for cancer.
There is no efficacy or safety data yet to support the use of Actemra in COVID-19 infections, but Chinese researchers are carrying out an 188-patient clinical trial in patients infected with the virus. Preliminary results in 14 patients have suggested however it may be able to help in subjects who have progressed to severe lung disease.
https://www.pmlive.com/pharma_news/china_backs_use_of_roches_actemra_for_coronavirus_1328014?SQ_DESIGN_NAME=2&
Comments
Be the first to add a comment
Log in to comment